A fatal genetic brain disorder with no cure may have a promising new therapeutic target. Researchers found that blocking the immune cGAS-STING pathway in a humanized mouse model of Huntington disease reduced brain inflammation, protected vulnerable neurons and improved movement. The findings identify a key driver of disease progression and suggest that targeting this pathway could offer a potential strategy for slowing the neurodegeneration that robs patients of their movement, cognition and independence.